4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001584759-26-000006
Director sold 6,700 shares at $12.00 ($80,431)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Heyman Richard A. Director | 2026-01-16 | Sale 10b5-1 | −3,500 | $12.00 | $42,016 | 41,800 | D |
| Heyman Richard A. Director | 2026-01-16 | Sale 10b5-1 | −3,200 | $12.00 | $38,415 | 213,072 | I |
| Open-market sales · 6,700 sh · avg $12.00 · $80,431 | |||||||
Loading xslF345X05/form4-01212026_120124.xml…